Search Login Register
Reperfusion Injury
Summary
Description:
Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY.
Also Known As:
Injury, Ischemia-Reperfusion; Injury, Reperfusion; Reperfusion Damage; Damage, Reperfusion; Damages, Reperfusion Show All >>
Networked: 15492
relevant articles (1694 outcomes,
2100 trials/studies)
for this Disease
Key Drugs and Agents for Reperfusion Injury
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Nitric Oxide (Nitrogen Monoxide)
:
46 outcomes 55 studies in 534 results
:
FDA 1
-
Oxygen
:
39 outcomes 79 studies in 720 results
: IBA
-
Superoxide Dismutase
:
33 outcomes 27 studies in 199 results
: IBA
-
Melatonin
:
25 outcomes 20 studies in 125 results
: IBA
-
Adenosine Triphosphate (ATP)
:
24 outcomes 29 studies in 237 results
: IBA
-
Adenosine
:
23 outcomes 26 studies in 198 results
:
FDA 19
Generic
-
Phosphotransferases (Kinase)
:
21 outcomes 26 studies in 225 results
: IBA
-
Acetylcysteine (Siran)
:
20 outcomes 23 studies in 109 results
:
FDA 17
Generic
-
Allopurinol (Remid)
:
19 outcomes 22 studies in 120 results
:
FDA 25
Generic
-
Retinaldehyde (Retinal)
:
18 outcomes 36 studies in 168 results
: IBA
Show All >>
Diseases Related to Reperfusion Injury
-
Ischemia
-
Myocardial Ischemia (Ischemic Heart Diseases)
-
Brain Ischemia (Cerebral Ischemia)
-
Inflammation
-
Myocardial Infarction
Show All >>
Key Therapies for Reperfusion Injury
Efficacy Chart >>
-
Transplants (Transplant)
:
72 outcomes 67 studies in 893 results
-
Transplantation (Transplant Recipients)
:
38 outcomes 40 studies in 514 results
-
Lung Transplantation
:
27 outcomes 23 studies in 264 results
-
Homologous Transplantation (Allograft)
:
24 outcomes 25 studies in 322 results
-
Ischemic Postconditioning
:
24 outcomes 18 studies in 167 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.